1Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators [ J ]. N Eng1 J Med, 1998,338: 853 - 860.
2Lucas GM, Chaisson RE, Moore RD. Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions[J]. Ann Intern Med, 1999; 131:81 - 87.
3Carr A, Cooper DA.Adverse effects of antiretroviral therapy [ J ].Lancet, 2000,356:1423 - 1430.
5Brinkman K, ter Hofstede HJM, Burger DM, et al. Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway[J]. AIDS, 1998,12:1735 - 1744.
6Lonergan JT, Behling C, Pfander H, et al. Hyperlactatemia and hepatic abnormalities in 10 human immunodeficiency virus-infected patients receiving uncleoside analogue combination regimens[J]. Clin Infect Dis,2000,31(1) :162- 166.
7Harris M, Tesiorowski A, Chan K, et al. Lactic acidosis complicating antiretroviral therapy: frequency and correlates [ abstract 36 ] [ J ]. Antivir Ther,2000,5(Suppl 2) :31.
8Medina DJ, Tsai CH, Hsiung GD, et al. Comparison of mitochondrial morphology, mitochondrial DNA content, and cell viability in cultured cells treated with three anti-human immunodeficiency virus dideoxynucleosides[ J ]. Antimicrob Agents Chemother, 1994,38 (8):1824 - 1828.
9Martin JL, Brown CE, Matthews-Davis N, et al. Effects of antiviral nucleoside analogs on human DNA polymerases and mitochondrial DNA synthesis[J ]. Antimicrob Agents Chemother, 1994,38: 2743 -2749.
10Schramm C, Wanitschke R, Galle PR. Thiamine for the treatment of nucleoside analogue-induced severe lactic acidosis [J ]. Eur J Anaesthesiol, 1999,16:733 - 735.
